Charles D. Lopez, M.D., Ph.D.
- Professor of Medicine, School of Medicine
- Cell and Developmental Biology Graduate Program, School of Medicine
- Cancer Biology Graduate Program, School of Medicine
- Program in Molecular and Cellular Biosciences, School of Medicine
Biography
My major research interest is investigating the basic cellular and molecular mechanisms of how tumors form and respond to treatment. By studying how these things work, I hope to find specific molecules that are targets for new cancer treatments. I see patients with gastrointestinal (digestive system) cancers and participate in clinical trials for a variety of gastrointestinal cancers.
Education and training
-
Degrees
- Ph.D., 1990, University of California San Francisco
- M.D., 1991, University of California San Francisco
-
Residency
- University of California Medical Center, San Francisco, 1994
-
Fellowship
- Medical oncology, Stanford University Medical Center, 1998
-
Certifications
- American Board of Internal Medicine, Medical Oncology
Memberships and associations:
- American Society of Clinical Oncology (ASCO)
Publications
Elsevier pure profilePublications
Ongoing replication stress tolerance and clonal T cell responses distinguish liver and lung recurrence and outcomes in pancreatic cancer
Nature CancerA Modified Floxuridine Reduced-Dose Protocol for Patients with Unresectable Colorectal Liver Metastases Treated with Hepatic Arterial Infusion
Annals of surgical oncologyASO Author Reflections
Annals of surgical oncologyCASPER
Future OncologyCirculating Neoplastic-Immune Hybrid Cells Are Biomarkers of Occult Metastasis and Treatment Response in Pancreatic Cancer
CancersDevimistat (CPI-613) With Modified Fluorouarcil, Oxaliplatin, Irinotecan, and Leucovorin (FFX) Versus FFX for Patients With Metastatic Adenocarcinoma of the Pancreas
Journal of Clinical OncologyExploratory Analyses of Circulating Neoplastic-Immune Hybrid Cells as Prognostic Biomarkers in Advanced Intrahepatic Cholangiocarcinoma
International journal of molecular sciencesGastroenteropancreatic neuroendocrine tumors
Current problems in cancerAccessible high-throughput single-cell whole-genome sequencing with paired chromatin accessibility
Cell Reports MethodsAdjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma
Journal of Clinical OncologyAtezolizumab Plus PEGPH20 Versus Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma and Gastric Cancer
OncologistEfficacy and safety of maintenance therapy with pamiparib versus placebo for advanced gastric cancer responding to first-line platinum-based chemotherapy
Cancer medicineHepatectomy is associated with improved oncologic outcomes in recurrent colorectal liver metastases
Surgery (United States)Modulation of myeloid and T cells in vivo by Bruton's tyrosine kinase inhibitor ibrutinib in patients with metastatic pancreatic ductal adenocarcinoma
Journal for immunotherapy of cancerNeoadjuvant therapy does not impact the biliary microbiome in patients with pancreatic cancer
Journal of surgical oncologyPembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966)
The LancetPhase 2 study of preoperative chemotherapy with nab-paclitaxel and gemcitabine followed by chemoradiation for borderline resectable or node-positive pancreatic ductal adenocarcinoma
Cancer medicineSocioeconomic and Geographic Disparities in the Referral and Treatment of Pancreatic Cancer at High-Volume Centers
JAMA SurgeryAlternative splicing of Apoptosis Stimulating Protein of TP53-2 (ASPP2) results in an oncogenic isoform promoting migration and therapy resistance in soft tissue sarcoma (STS)
BMC cancerEarly Versus Late Recurrence in Rectal Cancer
Journal of Gastrointestinal SurgeryHepatic arterial infusion pump chemotherapy combined with systemic therapy for patients with advanced colorectal liver metastases
Journal of surgical oncologyNeoadjuvant Therapy Is Associated with Improved Chemotherapy Delivery and Overall Survival Compared to Upfront Resection in Pancreatic Cancer without Increasing Perioperative Complications
CancersApplication of ASCO Value Framework to Treatment Advances in Hepatocellular Carcinoma
JCO Oncology PracticeASPP2κ Is Expressed In Human Colorectal Carcinoma And Promotes Chemotherapy Resistance And Tumorigenesis
Frontiers in Molecular BiosciencesCirculating Hybrid Cells
Annals of surgical oncologyDegree of biliary tract violation during treatment of gallbladder adenocarcinoma is independently associated with development of peritoneal carcinomatosis
Journal of surgical oncologyDetection of Tumor Multifocality in Resectable Intrahepatic Cholangiocarcinoma
Journal of Gastrointestinal SurgeryEffect of Time to Surgery of Colorectal Liver Metastases on Survival
Journal of Gastrointestinal CancerGeographic Disparities in Referral Rates and Oncologic Outcomes of Intrahepatic Cholangiocarcinoma
Annals of surgical oncology